PubMed · 15899746
Propofol: an immunomodulating agent.
Abstract
Propofol (2,6-diisopropylphenol) is a potent intravenous hypnotic agent widely administered for induction and maintenance of anesthesia and for sedation in the intensive care unit. Propofol is insoluble in water and therefore is formulated in a lipid emulsion. In addition, a preservative (ethylenediaminetetraacetic acid [EDTA] or sodium metabisulfite) is added to retard bacterial growth. Propofol has antiinflammatory properties, decreasing production of proinflammatory cytokines, altering expression of nitric oxide, and inhibiting neutrophil function. Propofol also is a potent antioxidant. The added preservatives have biologic activity; EDTA has antiinflammatory properties, whereas metabisulfite may cause lipid peroxidation. The antiinflammatory and antioxidant properties of propofol may have beneficial effects in patients with sepsis and systemic inflammatory response syndrome.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Paul E Marik. 2005. Propofol: an immunomodulating agent.. https://doi.org/10.1592/phco.2005.25.5_part_2.28s
Cite the original work for its findings. Save a collection to share your selection of sources.